RCE 2.86% 51.0¢ recce pharmaceuticals ltd

Ann: Expansion and Acceleration of Clinical Programs, page-5

  1. 5,354 Posts.
    lightbulb Created with Sketch. 689
    They seem to be saying diabetic ulcer infection trial will commence as a result of the success of ongoing burns trial. Strange no actual mention of progress or results or data in burns trial? Surely this was perfect opportunity for some sort of update?
    From what I've read about diabetic sores and similar for bed ridden patients etc it certainly does sound like another valuable path. Please let us know what is happening with burns trial though. After the initial announcement of progress in December it is frustrating nothing new has appeared on this topic.
    Last edited by andrewk65: 27/09/22
 
watchlist Created with Sketch. Add RCE (ASX) to my watchlist
(20min delay)
Last
51.0¢
Change
-0.015(2.86%)
Mkt cap ! $118.1M
Open High Low Value Volume
52.0¢ 52.0¢ 50.5¢ $40.89K 79.63K

Buyers (Bids)

No. Vol. Price($)
1 677 51.0¢
 

Sellers (Offers)

Price($) Vol. No.
52.5¢ 392 1
View Market Depth
Last trade - 15.59pm 13/09/2024 (20 minute delay) ?
RCE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.